Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 4/20 | 0.38 |
| ▸ | RARB | P10826 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | CAPN9 | O14815 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.33 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1297069 | 1.00 | PPARG (0.38) | PPARGRARBESR1CAPN9CHRM2 | |
| SCHEMBL1297755 | 1.00 | PPARG (0.38) | PPARGRARBESR1CAPN9CHRM2 | |
| SCHEMBL1298066 | 1.00 | PPARG (0.38) | PPARGRARBESR1CAPN9CHRM2 | |
| SCHEMBL1297845 | 1.00 | PPARG (0.38) | PPARGRARBESR1CAPN9CHRM2 | |
| SCHEMBL1297542 | 1.00 | PPARG (0.38) | PPARGRARBESR1CAPN9CHRM2 | |
| SCHEMBL9987382 | 1.00 | PPARG (0.38) | PPARGRARBESR1CAPN9CHRM2 | |
| SCHEMBL1296874 | 1.00 | PPARG (0.38) | PPARGRARBESR1CAPN9CHRM2 | |
| SCHEMBL1297837 | 1.00 | PPARG (0.38) | PPARGRARBESR1CAPN9CHRM2 | |
| SCHEMBL1297833 | 1.00 | PPARG (0.38) | PPARGRARBESR1CAPN9CHRM2 | |
| SCHEMBL1297876 | 1.00 | PPARG (0.38) | PPARGRARBESR1CAPN9CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8889748-B2 | Process for producing expandable styrene polymer compositions | BASF SE (DE) | 2014-11-18 | — | — | US | disclosed |
| US-8535436-B2 | Use of cyclohexane polycarboxylic acid derivatives for removing dust from chemical construction products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-09-17 | — | — | US | disclosed |
| US-8454744-B2 | Use of polyols and cyclohexane polycarboxylic acid derivatives for the removal of dust from chemical construction products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-20120138206-A1 | ADHESIVES AND SEALANTS CONTAINING CYCLOHEXANE POLYCARBOXYLIC ACID DERIVATIVES | BASF SE (DE) | 2012-06-07 | — | — | US | disclosed |
| US-20110291040-A1 | PROCESS FOR PRODUCING EXPANDABLE STYRENE POLYMER COMPOSITIONS | BASF SE (DE) | 2011-12-01 | — | — | US | disclosed |
| US-20110265693-A1 | Use Of Polyols And Cyclohexane Polycarboxylic Acid Derivatives For The Removal Of Dust From Chemical Construction Products | Construction Research & Tecnology GMBH (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20110232825-A1 | CYCLOHEXANE POLYCARBOXYLIC ACID DERIVATIVES AS PLASTICIZERS FOR ADHESIVES AND SEALANTS | BASF SE (DE) | 2011-09-29 | — | — | US | disclosed |
| US-20110209644-A1 | Use of Cyclohexane Polycarboxylic Acid Derivatives For Removing Dust From Chemical Construction Products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2011-09-01 | — | — | US | disclosed |
| US-7337913-B2 | Single piece closure device made of PVC | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-04 | — | — | US | disclosed |
| US-20050106405-A1 | Single piece closure device made of pvc | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110209644-A1 | Use of Cyclohexane Polycarboxylic Acid Derivatives For Removing Dust From Chemical Construction Products | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HPD, HCAR2 | PPARG 1633/4885RARB 4573/4885ESR1 4684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.